{"schemaVersion":1,"canonicalUrl":"https://namedproof.com/knowledge/en/sponsored-research-independence","topicId":"03","locale":"en","title":"Can sponsored research be independent? Check funding, control and publication","description":"Assess sponsored research through funding, data access, analysis, editorial control and publication rights. Understand what disclosure and independence can establish.","answer":"Sponsored research can preserve a researcher’s freedom to reach a conclusion, but payment creates a relationship readers should inspect. Assess independence through the actual controls over the question, data, analysis, wording and publication. Disclosure makes those relationships visible; it cannot establish that bias is absent.","category":"Expert assessments","author":{"type":"Organization","name":"NamedProof","url":"https://namedproof.com/about"},"publishedAt":"2026-10-17","sourceCheckedAt":"2026-10-17","sections":[{"id":"different-controls","title":"Ask who controls each stage","paragraphs":[{"text":"A company may fund a useful investigation because it needs evidence that would otherwise not exist. That commercial reason does not tell you how the investigation was performed. The practical question is whether the investigator could find and report something the sponsor did not want to hear.","sources":[]},{"text":"Follow the work from the brief to the public page. Who chose the comparison? Who supplied the samples? Could the investigator examine contradictory evidence? Who decided how results were summarized? A sponsor might leave the final prose untouched while controlling the data or comparison so tightly that an important weakness never enters the investigation.","sources":[]},{"text":"ICMJE recommends that medical-journal authors avoid sponsor agreements that obstruct data access or independent analysis and publication. This is scholarly guidance with a defined context. For a commercial assessment, use it to identify questions to ask rather than claim that the arrangement meets a universal certification.","sources":["S22"]}]},{"id":"research-finding","title":"What the sponsorship evidence actually says","paragraphs":[{"text":"A Cochrane review published in 2017 included 75 empirical papers about sponsorship of drug and medical-device studies. Favorable efficacy results were more frequent with industry sponsorship: pooled risk ratio 1.27, 95% confidence interval 1.17–1.37, from 25 papers, rated moderate-quality evidence. Searches extended through 2015. This result concerns that research population; it is not a measured bias rate for software reviews, NamedProof or present-day commercial assessments.","sources":["F01"]},{"text":"The risk ratio does not mean that 27% of all funded reports are false. It compares the frequency of favorable results across sponsorship groups in the included evidence. Nor can that aggregate finding tell you whether an individual report is wrong. The reader still has to inspect the report’s methods and the connection between its results and conclusion.","sources":["F01"]},{"text":"A transparent commercial review should therefore expose possible routes of influence. Publishing a funding label while concealing the selected comparison or missing evidence leaves the central evaluation unfinished. That is the reasoning behind the control checklist below, not an estimate of how often a particular sponsor intervenes.","sources":[]}]},{"id":"control-matrix","title":"A funding-and-control checklist","paragraphs":[{"text":"A reviewer can answer these questions without revealing confidential raw data publicly. Where access is restricted, state who could inspect the evidence and what an outside reader cannot verify. Confidentiality is a limit to describe, not a substitute for support.","sources":[]}],"table":{"caption":"NamedProof’s practical checklist for a funded assessment. Each answer needs the actual agreement or work record; a yes/no label is not independent verification.","headers":["Stage","Question to ask","Useful record"],"rows":[["Brief","Could the investigator narrow or challenge an unanswerable claim?","Agreed question, criteria and exclusions"],["Evidence","Who selected and supplied data, samples and comparison products?","Selection method and access limitations"],["Analysis","Could the investigator use an appropriate method and record exceptions?","Procedure, analysis notes and contrary evidence"],["Conclusions","Could the sponsor demand a different verdict or delete criticism?","Editorial rights and revision history"],["Compensation","Did payment depend on approval, a positive result or publication?","Accepted compensation terms"],["Publication","Could the sponsor keep the completed work private?","Publication policy and disclosure of selection"]],"sources":[]}},{"id":"hypothetical","title":"A hypothetical review can be independent in one sense and selected in another","paragraphs":[{"text":"Suppose a supplier pays a fixed fee for an analyst to compare an export feature against an agreed requirement. The analyst records a serious failure, receives the agreed fee and refuses to soften the conclusion. The supplier then keeps the assessment private under a pre-agreed publication choice. This is a hypothetical example, not a report of a NamedProof assignment.","sources":[]},{"text":"The analyst may have retained control of the conclusion. The public cannot infer that the visible collection represents every completed assessment, because this negative result is absent. Editorial independence and completeness of the public record are distinct properties. Both can matter to a buyer who is relying on the library.","sources":[]},{"text":"If only selected favorable reports are visible, a public reader should avoid treating the average visible outcome as an overall success rate. Knowing how the library was assembled is part of understanding the evidence, even when every published report is reproduced accurately.","sources":[]}]},{"id":"namedproof-scope","title":"How to read NamedProof’s stated model","paragraphs":[{"text":"NamedProof states that companies pay for the work, experts control conclusions and compensation does not depend on the verdict or publication choice. For new orders, the company can keep the completed assessment private or approve the complete public record. These policies describe the service model; they do not demonstrate a measured absence of sponsor influence.","sources":["NP02"]},{"text":"NamedProof also states that its public library is a sponsor-selected subset of commissioned work. Read a published assessment as evidence about its own question and scope, rather than evidence about every commissioned assessment or an entire market.","sources":["NP01"]},{"text":"Before commissioning or relying on funded work, obtain the brief, relevant relationships, editorial rights and publication terms together. If a decisive control remains unknown, record that gap explicitly. You can then choose whether the available evidence is sufficient for the decision or whether a different investigation is needed.","sources":[]}]}],"sources":[{"id":"S22","title":"Disclosure of Relationships, Activities and Conflicts of Interest","url":"https://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities--conflicts-of-interest.html","checkedAt":"2026-10-17","scope":"Medical journal research/publication practice.","limitations":"Relationship is not automatic proof of distortion; disclosure does not remove bias. Do not convert guidance to universal commercial contract law.","readExtent":"Official disclosure sections read"},{"id":"F01","title":"Industry sponsorship and research outcome","url":"https://www.cochrane.org/evidence/MR000033_industry-sponsorship-and-research-outcome","checkedAt":"2026-10-17","scope":"Cochrane 2017 review of empirical papers comparing industry and other sponsorship of drug/device studies; searches to 2015.","limitations":"Official plain-language summary and full structured abstract, including methods, results and quality ratings, read 17 October 2026; not the full review.","readExtent":"Official source read; details in scope and limitations"},{"id":"NP02","title":"NamedProof: Independence and ethics","url":"https://namedproof.com/independence","checkedAt":"2026-10-17","scope":"NamedProof authorship, compensation and publication policy, checked 17 October 2026.","limitations":"Manual editorial standards; not a guarantee of zero bias or automatic proof of authorship.","readExtent":"Official source read; details in scope and limitations"},{"id":"NP01","title":"NamedProof: About","url":"https://namedproof.com/about","checkedAt":"2026-10-17","scope":"NamedProof public description of commissioned assessments and generated profiles, checked 17 October 2026.","limitations":"Service policy and stated process; not evidence of completed client outcomes or an independently certified control.","readExtent":"Official source read; details in scope and limitations"}],"relatedTopicIds":["01","04","10"],"methodNote":"NamedProof editorial guide. Prepared with AI-assisted research and synthesis; the cited primary-source passages were checked for this guide. This is not a commissioned expert assessment and has not received human expert review. Examples labelled hypothetical are teaching examples, not client results.","limitations":["The Cochrane finding is limited to sponsorship comparisons of drug/device studies in the 2017 review, with searches through 2015. It is not a numerical estimate for NamedProof or other industries.","NamedProof publishes this commercially relevant editorial guide; it is not an independent assessment of NamedProof."],"originalContribution":"A stage-by-stage funding/control matrix and a hypothetical case separating editorial control from sponsor-selected publication.","relatedArticles":[{"title":"What is an independent expert assessment? Scope, evidence and deliverables","locale":"en","canonicalUrl":"https://namedproof.com/knowledge/en/independent-expert-assessment"},{"title":"Conflict-of-interest disclosure: what to record in an expert review","locale":"en","canonicalUrl":"https://namedproof.com/knowledge/en/conflict-of-interest-disclosure"},{"title":"Publication choices and negative findings: how to read a selected review library","locale":"en","canonicalUrl":"https://namedproof.com/knowledge/en/publication-choices-negative-findings"}],"availableTranslations":[{"title":"Can sponsored research be independent? Check funding, control and publication","locale":"en","canonicalUrl":"https://namedproof.com/knowledge/en/sponsored-research-independence"},{"title":"Kann gesponserte Forschung unabhängig sein? Finanzierung, Kontrolle und Veröffentlichung","locale":"de","canonicalUrl":"https://namedproof.com/knowledge/de/gesponserte-forschung-unabhaengigkeit"},{"title":"Une recherche financée par une entreprise peut-elle être indépendante ?","locale":"fr","canonicalUrl":"https://namedproof.com/knowledge/fr/recherche-financee-independance"},{"title":"¿Puede ser independiente la investigación financiada? Revisa financiación, control y publicación","locale":"es","canonicalUrl":"https://namedproof.com/knowledge/es/investigacion-financiada-independencia"}]}